NCT07646223

Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-10-01Est. Completion: 2032-12-31

Enrollment target: 140 participants

Locations

Contact

Colitis, Ulcerative

Disease activity and response to therapy in ulcerative colitis (UC) can be assessed by a range of endpoints including sy…

Ypsilanti, United StatesCompleted Apr 13, 2026

Inflammatory Bowel DiseasesCrohn's DiseaseSkin DiseasesDermatitis

The main objective of this study is to evaluate the change in the relative abundance of S. aureus within the lesion-site…

Millau, FranceEst. completion Sep 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.